JAKE DAILEY: Open Payments
NPI 1447792478 · VIDALIA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 17 payments from 11 companies in 2025. Trend: 2023 $653 · 2024 $647 · 2025 $357
Food & beverage: $357
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $71 |
| Grifols USA, LLC | 2 | $62 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| GENZYME CORPORATION | 2 | $37 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Hikma Pharmaceuticals USA | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| Octapharma USA, Inc. | 1 | $14 |
Products named: QULIPTA, Prolastin-C Liquid, VERQUVO, SHINGRIX, Ryaltris, Dexcom G6 Transmitter, MOUNJARO, PANZYGA.
Industry payments across GA — which companies pay providers there.
